SCHEMBL6826587

SCHEMBL6826587

Cc1c([N+](=O)[O-])cc(Cl)c2c1c1ccccc1n2C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.48
MEN1 O00255 5/20 0.48
NPY5R Q15761 2/20 0.40
PRKD3 O94806 1/20 0.37
PRKCG P05129 1/20 0.37
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKCH P24723 1/20 0.37
PRKCI P41743 1/20 0.37
PRKCE Q02156 1/20 0.37
PRKCQ Q04759 1/20 0.37
PRKCZ Q05513 1/20 0.37
PRKCD Q05655 1/20 0.37
PRKD1 Q15139 1/20 0.37
MAPT P10636 6/20 0.36
TDP1 Q9NUW8 5/20 0.36
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HTT P42858 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986693 0.80 MEN1 (0.56) KMT2AMEN1NPY5RMAPTTDP1
SCHEMBL27604176 0.78 KMT2A (0.57) KMT2AMEN1NPY5RMAPTTDP1
Hydrochloric Acid SCHEMBL6828981 0.77 NPY5R (0.40) KMT2AMEN1NPY5RPRKD3PRKCG
SCHEMBL6826791 0.72 CYP1A2 (0.40) KMT2AMEN1NPY5RMAPTTDP1
SCHEMBL6827501 0.71 MEN1 (0.54) KMT2AMEN1NPY5RMAPTTDP1
SCHEMBL7974800 0.70 MEN1 (0.64) KMT2AMEN1NPY5RMAPTTDP1
SCHEMBL6826569 0.69 KMT2A (0.56) KMT2AMEN1NPY5RPRKD3PRKCG
SCHEMBL6827271 0.67 NPY5R (0.50) KMT2AMEN1NPY5RPRKD3PRKCG
SCHEMBL6991407 0.67 KMT2A (0.49) KMT2AMEN1NPY5RPRKD3PRKCG
SCHEMBL6827505 0.67 KMT2A (0.41) KMT2AMEN1NPY5RMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1531527-A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands 2004-09-22 CN disclosed
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed
EP-1358157-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS AstraZeneca AB (SE) 2003-11-05 EP disclosed
WO-2002051806-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands NPY5R, NPY1R, NPY2R KMT2A 3618/4885MEN1 767/4885NPY5R 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.